Literature DB >> 7430354

Antimicrobial susceptibilities of Clostridium difficile.

R Shuttleworth, M Taylor, D M Jones.   

Abstract

The antimicrobial susceptibilities of 78 strains of Clostridium difficile isolated from patients with and without gastrointestinal symptoms were determined and compared. Strains from patients with symptoms were more likely to show resistance to antibiotics. The antimicrobial susceptibilities of toxigenic and non-toxigenic strains were found to be similar.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7430354      PMCID： PMC1146303          DOI： 10.1136/jcp.33.10.1002

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  8 in total

1.  Relapse of pseudomembranous colitis after vancomycin therapy.

Authors:  W L George; N A Volpicelli; D B Stiner; D D Richman; E J Liechty; H Y Mok; R D Rolfe; S M Finegold
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

2.  Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.

Authors:  D B Silk; P N Trewby; R A Chase; P J Mellon; M A Hanid; M Davies; P G Langley; P G Wheeler; R Williams
Journal:  Lancet       Date:  1977-07-02       Impact factor: 79.321

3.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

4.  Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Authors:  F Tedesco; R Markham; M Gurwith; D Christie; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

5.  Antibiotic susceptibility of Clostridium difficile.

Authors:  D W Burdon; J D Brown; D J Youngs; Y Arabi; N Shinagawa; J Alexander-Williams; M R Keighley; R H George
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

6.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

7.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

8.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321
  8 in total
  13 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Treatment of refractory and recurrent Clostridium difficile infection.

Authors:  Christina M Surawicz; Jacob Alexander
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-19       Impact factor: 46.802

3.  Household pets as a potential reservoir for Clostridium difficile infection.

Authors:  S P Borriello; P Honour; T Turner; F Barclay
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

4.  Molecular cloning and genetic analysis of a chloramphenicol acetyltransferase determinant from Clostridium difficile.

Authors:  B W Wren; P Mullany; C Clayton; S Tabaqchali
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

6.  Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens.

Authors:  S P Borriello; P Honour
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

7.  Effect of clindamycin on the ability of a continuous culture of colonic bacteria to ferment carbohydrate.

Authors:  C A Edwards; B I Duerden; N W Read
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

8.  Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.

Authors:  M J Wolfhagen; K Meijer; A C Fluit; R Torensma; R A Bruinsma; A Fleer; J Verhoef
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

9.  Case report of Plesiomonas shigelloides-associated persistent dysentery and pseudomembranous colitis.

Authors:  F P van Loon; Z Rahim; K A Chowdhury; B A Kay; S A Rahman
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

Review 10.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.